“The number of cancer survivors in the United States has been increasing fairly exponentially over the past 30 years or so,” said Jennifer A. Ligibel, MD, Assistant Professor, Department of Medicine, Harvard Medical School, and Senior Physician, Adult Oncology, Dana-Farber Cancer Institute, Boston. But survivorship care is still an often overlooked part of the continuum of cancer care, and many survivors and families are “lost in transition.”1
To better address the issues faced by cancer survivors and their families and to offer practical recommendations for oncology health care teams to implement in the clinic, NCCN created NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) on survivorship care. “They are intended as a library of tools for a provider to use when assessing and treating a cancer survivor,” reported Crystal S. Denlinger, MD, Assistant Professor and Attending Oncologist, Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, and Chair of the NCCN Survivorship Panel. Considering the current heterogeneity in how survivorship care is delivered across the country, these guidelines could help provide a framework for the delivery of that care in the future, added Dr. Ligibel, who is also a member of the NCCN Survivorship Panel.
Dr. Ligibel has disclosed that she has no financial interests, arrangements, or commercial interest conflicts with the manufacturers of any products discussed in this article or their competitors. Dr. Denlinger has disclosed that she receives research support from AstraZeneca Pharmaceuticals LP; MedImmune Inc.; and Merrimack Pharmaceuticals.
Ballard-BarbashRFriedenreichCMCourneyaKS. Physical activity, biomarkers, and disease outcomes in cancer survivors: a systematic review. J Natl Cancer Inst2012;104:815–840.
MeyerhardtJAHeseltineDNiedzwieckiD. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol2006;24:3535–3541.
RichmanELKenfieldSAStampferMJ. Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor. Cancer Res2011;71:3889–3895.
WefelJSVardyJAhlesTSchagenSB. International Cognition and Cancer Task Force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol2011;12:703–708.